Nahal B, Owen E, Jama M, Obasi A, Clarke E
BMJ Glob Health. 2024; 9(7).
PMID: 38964883
PMC: 11227752.
DOI: 10.1136/bmjgh-2023-012719.
Zee T, Bin Abdul Aziz M, Wei P
Dev World Bioeth. 2023; 24(4):331-341.
PMID: 37997006
PMC: 11111594.
DOI: 10.1111/dewb.12435.
Kabore Y, Vatrinet R, Guindo O, Moussa S, Schilling W, Grais R
Am J Trop Med Hyg. 2023; 109(3):511-514.
PMID: 37580026
PMC: 10484280.
DOI: 10.4269/ajtmh.22-0606.
Gilgoff J, Park E, Price J, Scott T, Moyd T, Rouse K
J Community Engagem Scholarsh. 2022; 15(1).
PMID: 36540657
PMC: 9762856.
DOI: 10.54656/jces.v15i1.479.
Leal M, Anaya-Rojas J, Munro M, Blunt J, Melian C, Calado R
Proc Natl Acad Sci U S A. 2020; 117(39):24165-24172.
PMID: 32929019
PMC: 7533840.
DOI: 10.1073/pnas.2007610117.
The role of corruption and unethical behaviour in precluding the placement of industry sponsored clinical trials in sub-Saharan Africa: Stakeholder views.
Egharevba E, Atkinson J
Contemp Clin Trials Commun. 2018; 3:102-110.
PMID: 29736462
PMC: 5935837.
DOI: 10.1016/j.conctc.2016.04.009.
International Clinical Trials in Latin American and Caribbean Countries: Research and Development to Meet Local Health Needs.
da Silva R, Amato A, Guilhem D, de Carvalho M, Novaes M
Front Pharmacol. 2018; 8:961.
PMID: 29354059
PMC: 5760498.
DOI: 10.3389/fphar.2017.00961.
Developing the ethics of implementation research in health.
Gopichandran V, Luyckx V, Biller-Andorno N, Fairchild A, Singh J, Tran N
Implement Sci. 2016; 11(1):161.
PMID: 27938400
PMC: 5148832.
DOI: 10.1186/s13012-016-0527-y.
Benefits in cash or in kind? A community consultation on types of benefits in health research on the Kenyan Coast.
Njue M, Molyneux S, Kombe F, Mwalukore S, Kamuya D, Marsh V
PLoS One. 2015; 10(5):e0127842.
PMID: 26010783
PMC: 4444261.
DOI: 10.1371/journal.pone.0127842.
A call for global governance of biobanks.
Chen H, Pang T
Bull World Health Organ. 2015; 93(2):113-7.
PMID: 25883404
PMC: 4339960.
DOI: 10.2471/BLT.14.138420.
The ethics of global clinical trials: In developing countries, participation in clinical trials is sometimes the only way to access medical treatment. What should be done to avoid exploitation of disadvantaged populations?.
Weigmann K
EMBO Rep. 2015; 16(5):566-70.
PMID: 25851646
PMC: 4428044.
DOI: 10.15252/embr.201540398.
Ethical considerations in conducting research on autism spectrum disorders in low and middle income countries.
Daley T, Singhal N, Krishnamurthy V
J Autism Dev Disord. 2013; 43(9):2002-14.
PMID: 23283629
DOI: 10.1007/s10803-012-1750-2.
Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.
Blanchard-Horan C, Stocker V, Moran L, Ferguson E, Klingman K, McMahon D
Appl Clin Trials. 2012; 21(1):34-42.
PMID: 22798719
PMC: 3392753.
Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coast.
Molyneux S, Mulupi S, Mbaabu L, Marsh V
BMC Med Ethics. 2012; 13:13.
PMID: 22726531
PMC: 3407030.
DOI: 10.1186/1472-6939-13-13.
Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya.
Lairumbi G, Parker M, Fitzpatrick R, English M
Philos Ethics Humanit Med. 2012; 7:7.
PMID: 22251457
PMC: 3274462.
DOI: 10.1186/1747-5341-7-7.
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.
Swysen C, Vekemans J, Bruls M, Oyakhirome S, Drakeley C, Kremsner P
Malar J. 2011; 10:223.
PMID: 21816032
PMC: 3220650.
DOI: 10.1186/1475-2875-10-223.